HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hao Sun Selected Research

ML216

12/2021BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hao Sun Research Topics

Disease

78Neoplasms (Cancer)
02/2022 - 08/2003
25Inflammation (Inflammations)
01/2022 - 12/2011
18Infections
10/2022 - 11/2008
15Stroke (Strokes)
01/2022 - 01/2011
14Neoplasm Metastasis (Metastasis)
01/2022 - 09/2014
12Pain (Aches)
01/2022 - 04/2010
12Myocardial Infarction
01/2022 - 12/2008
10Lung Neoplasms (Lung Cancer)
01/2022 - 11/2013
10Breast Neoplasms (Breast Cancer)
01/2022 - 11/2002
10Body Weight (Weight, Body)
07/2019 - 10/2011
8Carcinogenesis
07/2022 - 01/2013
8Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 12/2008
8Ischemic Stroke
01/2022 - 01/2011
7Hypertension (High Blood Pressure)
03/2022 - 12/2013
7Hemorrhage
01/2022 - 05/2015
7Fibrosis (Cirrhosis)
01/2022 - 01/2016
7Alzheimer Disease (Alzheimer's Disease)
12/2021 - 03/2010
7Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2018
6Stomach Neoplasms (Stomach Cancer)
02/2022 - 01/2019
6Congenital Abnormalities (Deformity)
01/2022 - 05/2013
6Pathologic Processes
12/2021 - 11/2008
6Wounds and Injuries (Trauma)
12/2020 - 10/2012
6Down Syndrome (Down's Syndrome)
11/2013 - 03/2010
5Hepatocellular Carcinoma (Hepatoma)
12/2022 - 02/2011
5Poisoning
03/2022 - 07/2019
5Leukemia
01/2022 - 11/2002
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2017
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2019
5Obesity
10/2021 - 01/2011
5Thrombosis (Thrombus)
01/2021 - 01/2014
5Type 2 Diabetes Mellitus (MODY)
07/2020 - 03/2009
4Lung Injury
01/2022 - 01/2016
4ST Elevation Myocardial Infarction
01/2022 - 12/2008
4Osteoarthritis
01/2022 - 01/2019
4Reperfusion Injury
01/2022 - 01/2017
4Disease Progression
12/2021 - 11/2008
4Adenoma (Adenomas)
11/2021 - 01/2019
4Carcinoma (Carcinomatosis)
01/2021 - 11/2002
4Insulin Resistance
01/2021 - 12/2011
4Multiple Sclerosis
01/2021 - 01/2012
4Coronary Artery Disease (Coronary Atherosclerosis)
11/2020 - 01/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2019 - 05/2014
4Pancreatitis
01/2019 - 06/2016
4Seizures (Absence Seizure)
01/2019 - 11/2008
3Ocular Hypertension (Glaucoma, Suspect)
12/2022 - 01/2019
3Urinary Bladder Neoplasms (Bladder Cancer)
05/2022 - 01/2018
3Hypoxia (Hypoxemia)
01/2022 - 05/2014
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 01/2017
3Nervous System Diseases (Neurological Disorders)
01/2022 - 01/2013

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2010
26Biomarkers (Surrogate Marker)IBA
04/2022 - 02/2011
20DNA (Deoxyribonucleic Acid)IBA
12/2020 - 03/2010
19Pharmaceutical PreparationsIBA
01/2022 - 11/2002
17MicroRNAs (MicroRNA)IBA
01/2022 - 11/2008
12Long Noncoding RNAIBA
01/2022 - 09/2014
11VaccinesIBA
01/2022 - 04/2004
9Biological ProductsIBA
12/2022 - 12/2014
9Peptides (Polypeptides)IBA
01/2022 - 01/2016
8Therapeutic UsesIBA
07/2022 - 01/2016
7EnzymesIBA
01/2022 - 11/2011
6ParaquatIBA
03/2022 - 01/2016
6Particulate MatterIBA
03/2022 - 06/2016
6AntigensIBA
01/2022 - 04/2004
6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2021
6IntegrinsIBA
01/2022 - 01/2018
6omega-Chloroacetophenone (Mace)IBA
01/2022 - 12/2008
6Messenger RNA (mRNA)IBA
01/2022 - 02/2011
6Retinaldehyde (Retinal)IBA
12/2021 - 01/2004
6CytokinesIBA
01/2020 - 06/2015
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
5CholesterolIBA
01/2022 - 03/2016
5LigandsIBA
01/2021 - 01/2016
4Complement System Proteins (Complement)IBA
12/2022 - 01/2021
4DexmedetomidineFDA Link
01/2022 - 12/2016
4HerbicidesIBA
01/2022 - 01/2016
4LipidsIBA
01/2022 - 08/2016
4Amyloid (Amyloid Fibrils)IBA
12/2021 - 01/2011
4Triglycerides (Triacylglycerol)IBA
01/2021 - 09/2015
4Contrast MediaIBA
01/2021 - 01/2012
4Insulin (Novolin)FDA Link
07/2020 - 01/2018
4IodineIBA
01/2020 - 12/2010
4Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2011
4Aluminum ChlorideIBA
03/2012 - 10/2011
4Drinking WaterIBA
03/2012 - 10/2011
3Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 05/2016
3Paclitaxel (Taxol)FDA LinkGeneric
03/2022 - 08/2016
3Ropivacaine (Naropin)FDA LinkGeneric
01/2022 - 12/2016
3antineoplaston A10 (A 10)IBA
01/2022 - 01/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 07/2015
3osimertinibIBA
01/2022 - 08/2019

Therapy/Procedure

37Therapeutics
01/2022 - 01/2012
9Radiotherapy
03/2022 - 01/2019
7Drug Therapy (Chemotherapy)
02/2022 - 09/2014
5Osteotomy
07/2022 - 05/2013
5Percutaneous Coronary Intervention
01/2022 - 12/2008
5Stents
01/2021 - 01/2014
4Immunotherapy
01/2022 - 06/2018
4External Fixators
02/2021 - 12/2017
4Intraperitoneal Injections
01/2021 - 01/2016
3Knee Replacement Arthroplasty (Total Knee Replacement)
06/2022 - 02/2017